Trial intelligence / Profile preview

Mirena versus placebo intrauterine system for chronic pelvic pain and dysmenorrhoea

ACTRN12608000029392Phase 3Recruiting

Sponsor
University of Sydney
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in chronic prostatitis (CP) and dysmenorrhea comparing Mirena intrauterine system insertion with Placebo intrauterine system insertion (2 arms). Primary endpoints: Daily ratings of dysmenorrhoea and Daily ratings of pelvic pain. Started Oct 2009; status: recruiting.

02

Drugs

avatrombopag
03

Conditions

chronic prostatitis (CP)dysmenorrhea

Beyond the preview

Go deeper on ACTRN12608000029392.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12608000029392.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call